Avalanche C-Chain marked an important milestone in the year 2025 by processing more than 400 million transactions, marking the most transactions processed on theAvalanche C-Chain marked an important milestone in the year 2025 by processing more than 400 million transactions, marking the most transactions processed on the

Avalanche (AVAX) Accumulation Pattern Hints at a Potential Rally Toward $253

Avalanche C-Chain marked an important milestone in the year 2025 by processing more than 400 million transactions, marking the most transactions processed on the network so far. It’s a sign that the network is maturing from the expansion phase to the actual operational phase.

Source: X

This is, of course, in addition to the critical function of the network remaining stable and performing well under heavy load conditions. Today, the C-Chain is firmly on course to reach the 1 billion cumulative transactions mark in the year 2026 and remain a stable and highly utilized blockchain infrastructure.

Also Read: Avalanche (AVAX) Price Action Signals Potential Expansion Move Toward $28 Target

AVAX’s Macro Accumulation Setup Points to $253

However, the crypto analyst, Nehal, highlighted that Avalanche’s (AVAX) accumulation pattern in the monthly chart is evident, and it is predicting a double bottom pattern, which is commonly seen at the time of reversal in trends. The price is still dependent on the support level of $8.83-$13.02, which indicates that there is consistent buying interest.

Source: X

Looking at the macro perspective, Avalanche’s potential also lines up with liquidity goals and fundamental developments. The first level of resistance stands around $170, while a more distant outlook pushes beyond $253 through 2026. Increased institutional adoption, subnet use, and overall cross-chain functionality through AWM support this hypothesis.

Downtrend Persists with Initial Signs of Stabilization

On the weekly chart, AVAX is still in a strong downtrend and currently trading around $12.55 after making lower highs and lower lows from the $40+ level. The price is currently below the previous levels of support. There is a strong downside wick indicating that it is a case of capitulation, but the fact that there is not much follow-through buying reveals that the buyers don’t have much conviction.

Source: TradingView

The momentum indicators remain in favor of selling, though the selling momentum is showing signs of deceleration. RSI values of 35 indicate strong selling momentum, though it is still far from an oversold level, while the MACD is below the zero line with a negative histogram. The critical level of support is pegged at $10-$11, and any breach here will increase the chances of a move to $7.50.

Also Read: Avalanche (AVAX) Eyes $13 After Forming Key Bullish Price Pattern

Market Opportunity
Avalanche Logo
Avalanche Price(AVAX)
$12.34
$12.34$12.34
-0.96%
USD
Avalanche (AVAX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Technology Group (NASDAQ:DJT) has announced plans to distribute a new digital token to its shareholders, leveraging Crypto.com‘s infraread more
Share
Coinstats2026/01/01 00:23
Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

CEO Vijit Katta shares with crypto.news how Tria is reshaping digital asset banking and paving the way for a frictionless, user-controlled financial future.
Share
Crypto.news2026/01/01 01:00
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29